Drain Paul K, Losina Elena, Coleman Sharon M, Giddy Janet, Ross Douglas, Katz Jeffrey N, Walensky Rochelle P, Freedberg Kenneth A, Bassett Ingrid V
Division of Infectious Diseases and Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, USA.
BMC Infect Dis. 2014 Feb 26;14:110. doi: 10.1186/1471-2334-14-110.
A rapid diagnostic test for active tuberculosis (TB) at the clinical point-of-care could expedite case detection and accelerate TB treatment initiation. We assessed the diagnostic accuracy of a rapid urine lipoarabinomannan (LAM) test for TB screening among HIV-infected adults in a TB-endemic setting.
We prospectively enrolled newly-diagnosed HIV-infected adults (≥18 years) at 4 outpatient clinics in Durban from Oct 2011-May 2012, excluding those on TB therapy. A physician evaluated all participants and offered CD4 cell count testing. Trained study nurses collected a sputum sample for acid-fast bacilli smear microscopy (AFB) and mycobacterial culture, and performed urine LAM testing using Determine™ TB LAM in the clinic. The presence of a band regardless of intensity on the urine LAM test was considered positive. We defined as the gold standard for active pulmonary TB a positive sputum culture for Mycobacterium tuberculosis. Diagnostic accuracy of urine LAM was assessed, alone and in combination with smear microscopy, and stratified by CD4 cell count.
Among 342 newly-diagnosed HIV-infected participants, 190 (56%) were male, mean age was 35.6 years, and median CD4 was 182/mm3. Sixty participants had culture-positive pulmonary TB, resulting in an estimated prevalence of 17.5% (95% CI 13.7-22.0%). Forty-five (13.2%) participants were urine LAM positive. Mean time from urine specimen collection to LAM test result was 40 minutes (95% CI 34-46 minutes). Urine LAM test sensitivity was 28.3% (95% CI 17.5-41.4) overall, and 37.5% (95% CI 21.1-56.3) for those with CD4 count <100/mm3, while specificity was 90.1% (95% CI 86.0-93.3) overall, and 86.9% (95% CI 75.8-94.2) for those with CD4 < 100/mm3. When combined with sputum AFB (either test positive), sensitivity increased to 38.3% (95% CI 26.0-51.8), but specificity decreased to 85.8% (95% CI 81.1-89.7).
In this prospective, clinic-based study with trained nurses, a rapid urine LAM test had low sensitivity for TB screening among newly-diagnosed HIV-infected adults, but improved sensitivity when combined with sputum smear microscopy.
在临床护理点进行的活动性结核病(TB)快速诊断检测可加快病例发现并加速结核病治疗的启动。我们评估了一种快速尿液脂阿拉伯甘露聚糖(LAM)检测在结核病流行地区对HIV感染成人进行结核病筛查的诊断准确性。
2011年10月至2012年5月,我们在德班的4家门诊前瞻性纳入了新诊断的HIV感染成人(≥18岁),排除正在接受结核病治疗的患者。一名医生对所有参与者进行评估并提供CD4细胞计数检测。经过培训的研究护士采集痰标本进行抗酸杆菌涂片显微镜检查(AFB)和分枝杆菌培养,并在诊所使用Determine™ TB LAM进行尿液LAM检测。尿液LAM检测中无论条带强度如何,出现条带即视为阳性。我们将结核分枝杆菌痰培养阳性定义为活动性肺结核的金标准。单独以及联合涂片显微镜检查评估尿液LAM的诊断准确性,并按CD4细胞计数分层。
在342名新诊断的HIV感染参与者中,190名(56%)为男性,平均年龄为35.6岁,CD4中位数为182/mm³。60名参与者痰培养确诊为肺结核,估计患病率为17.5%(95%CI 13.7 - 22.0%)。45名(13.2%)参与者尿液LAM检测呈阳性。从尿液标本采集到LAM检测结果的平均时间为40分钟(95%CI 34 - 46分钟)。尿液LAM检测总体敏感性为28.3%(95%CI 17.5 - 41.4),CD4计数<100/mm³者为37.5%(95%CI 21.1 - 56.3),而总体特异性为90.1%(95%CI 86.0 - 93.3),CD4<100/mm³者为86.9%(95%CI 75.8 - 94.2)。与痰AFB联合(任一检测呈阳性)时,敏感性增至38.3%(95%CI 26.0 - 51.8),但特异性降至85.8%(95%CI 81.1 - 89.7)。
在这项由经过培训的护士参与的前瞻性临床研究中,快速尿液LAM检测在新诊断的HIV感染成人结核病筛查中敏感性较低,但与痰涂片显微镜检查联合时敏感性有所提高。